Ryan Reeves, MD
Interventional Cardiology · San Diego, CANPI 1548440902
Payments from drug & device makers
Across 162 payments — averaging $377.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$40K
- Philips North America LLC$9K
- Edwards Lifesciences$8K
- Medtronic$1K
- Ancora Heart, Inc.$782
- Boston Scientific$724
- plus $1K from 8 others
Across 2 payments — averaging $75.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$150
What the payments were for
- Consulting fees$4,47519%
- Travel & lodging$11,96551%
- Food & beverage$7,24531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 49 | $39,886 |
| Philips North America LLC | 6 | $8,960 |
| Edwards Lifesciences | 42 | $8,105 |
| Medtronic(2 entities) | 14 | $1,356 |
| Ancora Heart, Inc. | 5 | $782 |
| Boston Scientific | 13 | $724 |
| Shockwave Medical, Inc | 4 | $362 |
| Terumo Medical Corporation | 8 | $324 |
| W. L. Gore & Associates, Inc. | 4 | $200 |
| Cardiva Medical, Inc. | 11 | $150 |
| Cardiovascular Systems Inc. | 3 | $108 |
| Biotronik Inc. | 1 | $79 |
| Endotronix, Inc. | 1 | $65 |
| Abiomed | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9547) IGT Systems Undivided$8,633
- Edwards SAPIEN 3 Transcatheter Heart Valve$674
- Resolute$340
- AMPLATZER$294
- CoreValve Evolut$263
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$220
- PASCAL$193
- RESOLUTE ONYX$168
- EVOQUE$161
- MitraClip$151
- ONYX FRONTIER$145
- Sentinel$141
- GORE CARDIOFORM Septal Occluder$139
- GENERAL - STENTS$136
- MitraClip System$126
- AMPLATZER AMULET$123
- Melody$118
- SYMPLICITY G3$115
- AMPLATZER Occluders$113
- Azurion 7 M20$113
How this compares
$61,118 in reported general payments places this provider in the 75th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 18 | $336 |
| Amlodipine Besylate | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in San Diego
- Ehtisham MahmudSan Diego$1.5M
- Mitul PatelSan Diego$852K
- Raghava GollapudiSan Diego$842K
- Lawrence AngSan Diego$384K
- Jeffrey CavendishSan Diego$355K
- Luke OakleySan Diego$317K
- Justin CoxSan Diego$291K
- Arvin NarulaSan Diego$285K
- Rajendra MakkarWest Hollywood$16.6M
- Fahed BitarCovina$9.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.